FDA’s call for innovation: AI-driven solutions for Parkinson’s freezing of gait detection and prediction

May 28, 2024

As digital health technologies proliferate, the US Food and Drug Administration (FDA) is taking a closer look at how they can capture information about a person’s health outside of a clinical setting.

For Parkinson’s disease, a handful of wearable technologies have already been cleared to track symptoms.

According to leading data and analytics company GlobalData, the market for neurological devices was valued at $12.5bn in 2023 and is expected to grow by a compound annual growth rate of 4.60% to reach $20.9bn by 2033.

Read More on Medical Device Network